Brain edema in acute liver failure: Can it be prevented? Can it be treated?

Journal of Hepatology

Volumn 46, Issue 4, 2007, Pages 564-569

  Blei, Andres T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; ANTIBIOTIC AGENT; MANNITOL; SODIUM CHLORIDE;

BRAIN EDEMA; HUMAN; HYPONATREMIA; INFECTION; INFLAMMATION; INTRACRANIAL PRESSURE MONITORING; LIVER FAILURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEIZURE;

BRAIN EDEMA; HUMANS; LIVER FAILURE, ACUTE;

EID: 33947095053     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.01.011     Document Type: Review

References (46)

1. Rubinstein A.A. Treatment of Cerebral Edema. Neurologist 12 (2006) 59-73
2. Agre P., Nielsen S., and Ottersen O.P. Towards a molecular understanding of water homeostasis in the brain. Neuroscience 129 (2004) 849-850
3. Manley G.T., Binder D.K., Papadopoulos M.C., and Verkman A.S. New insights into water transport and edema in the central nervous system from phenotype analysis of aquaporin-4 null mice. Neuroscience 129 (2004) 983-991
4. Nguyen J.H., Yamamoto S., Steers J., Sevlever D., Lin W., and Shimojima N. Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice. J Hepatol 44 (2006) 1105-1114
5. Bruewer M., Luegering A., Kucharzik T., Parkos C.A., Madara J.L., Hopkins A.M., et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 171 (2003) 6164-6172
6. Ranjan P., Mishra A.M., Kale R., Saraswat V.A., and Gupta R.K. Cytotoxic edema is responsible for raised intracranial pressure in fulminant hepatic failure: in vivo demonstration using diffusion-weighted MRI in human subjects. Metab Brain Dis 20 (2005) 181-192
7. Rama Rao K.V., Chen M., Simard J.M., and Norenberg M.D. Increased aquaporin-4 expression in ammonia-treated cultured astrocytes. Neuroreport 14 (2003) 2379-2382
8. Master S., Gottstein J., and Blei A.T. Cerebral blood flow and the development of ammonia-induced brain edema in rats after portacaval anastomosis. Hepatology 30 (1999) 876-880
9. Aggarwal S., Obrist W., Yonas H., Kramer D., Kang Y., Scott V., et al. Cerebral hemodynamic and metabolic profiles in fulminant hepatic failure: relationship to outcome. Liver Transpl 11 (2005) 1353-1360
10. Haussinger D., and Schliess F. Astrocyte swelling and protein tyrosine nitration in hepatic encephalopathy. Neurochem Int 47 (2005) 64-70
11. Albrecht J., and Norenberg M.D. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology 44 (2006) 788-794
12. Schiltz J.C., and Sawchenko P.E. Signaling the brain in systemic inflammation: the role of perivascular cells. Front Biosci 8 (2003) s1321-s1329
13. Blei A.T. Infection, inflammation and hepatic encephalopathy, synergism redefined. J Hepatol 40 (2004) 327-330
14. Bernuau J. Acute liver failure: avoidance of deleterious cofactors and early specific medical therapy for the liver are better than late intensive care for the brain. J Hepatol 41 (2004) 152-155
15. Elinav E., Ben-Dov I., Hai-Am E., Ackerman Z., and Ofran Y. The predictive value of admission and follow up factor V and VII levels in patients with acute hepatitis and coagulopathy. J Hepatol 42 (2005) 82-86
16. Clemmesen J.O., Larsen F.S., Kondrup J., Hansen B.A., and Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 29 (1999) 648-653
17. Bhatia V., Singh R., and Acharya S.K. Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut 55 (2006) 98-104
18. Hay J.E., Angulo P., and Lee W.M. Lactulose treatment in acute liver failure. J Hepatol 36 Suppl 1 (2002) 33
19. Rose C., Michalak A., Rao K.V., Quack G., Kircheis G., and Butterworth R.F. l-Ornithine-l-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure. Hepatology 30 (1999) 636-640
20. Cordoba J., Blei A.T., and Mujais S. Determinants of ammonia clearance by hemodialysis. Artif Organs 20 (1996) 800-803
21. Bhatia V., Batra Y., and Acharya S.K. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure - a controlled clinical trial. J Hepatol 41 (2004) 89-96
22. Larsen F.S., and Wendon J. Brain edema in liver failure: basic physiologic principles and management. Liver Transpl 8 11 (2002) 983-989
23. Rolando N., Wade J., Davalos M., Wendon J., Philpott-Howard J., and Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 32 (2000) 734-739
24. Vaquero J., Polson J., Chung C., Helenowski I., Schiodt F.V., Reisch J., et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 125 (2003) 755-764
25. Vaquero J., Chung C., Cahill M.E., and Blei A.T. Pathogenesis of hepatic encephalopathy in acute liver failure. Semin Liver Dis 23 (2003) 259-269
26. Antoniades C.G., Berry P.A., Davies E.T., Hussain M., Bernal W., Vergani D., et al. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 44 (2006) 34-43
27. Ellis A.J., Wenson J., and Williams R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology 32 (2000) 536-541
28. Vaquero J., and Butterworth R.F. The brain glutamate system in liver failure. J Neurochem 98 (2006) 661-669
29. Bernuau J., and Durand F. Intracranial pressure monitoring in patients with acute liver failure: a questionable invasive surveillance. Hepatology 44 (2006) 502-504
30. Wendon J.A., and Larsen F.S. Intracranial pressure monitoring in acute liver failure. A procedure with clear indications. Hepatology 44 (2006) 504-507
31. Blei A.T., Olafsson S., Webster S., and Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 341 (1993) 157-158
32. Vaquero J., Fontana R.J., Larson A.M., Bass N.M., Davern T.J., Shakil A.O., et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 11 (2005) 1581-1589
33. Shami V.M., Caldwell S.H., Hespenheide E.E., Arseneau K.O., Bickston S.J., and Macik B.G. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 9 (2003) 138-143
34. Strauss G.I., Knudsen G.M., Kondrup J., Moller K., and Larsen F.S. Cerebral metabolism of ammonia and amino acids in patients with fulminant hepatic failure. Gastroenterology 121 (2001) 1109-1119
35. Blei A.T. Monitoring cerebral blood flow: a useful clinical tool in acute liver failure?. Liver Transpl 11 (2005) 1320-1322
36. Murphy N., Auzinger G., Bernal W., and Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 39 (2004) 464-470
37. Ede R.J., Gimson A.E., Bihari D., and Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol 2 (1986) 43-51
38. Tofteng F., and Larsen F.S. The effect of indomethacin on intracranial pressure, cerebral perfusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 24 (2004) 798-804
39. Ben Abraham R., Szold O., Merhav H., Biderman P., Kidron A., Nakache R., et al. Rapid resolution of brain edema and improved cerebral perfusion pressure following the molecular adsorbent recycling system in acute liver failure patients. Transplant Proc 33 (2001) 2897-2899
40. Jalan R., Olde Damink S.W., Deutz N.E., Hayes P.C., and Lee A. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology 127 (2004) 1338-1346
41. Jalan R., Olde Damink S.W., Deutz N.E., Davies N.A., Garden O.J., Madhavan K.K., et al. Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation 75 (2003) 2034-2039
42. Vaquero J., Rose C., and Butterworth R.F. Keeping cool in acute liver failure: rationale for the use of mild hypothermia. J Hepatol 43 (2005) 1067-1077
43. 2) by mild hypothermia compared with thiopental. J Neurosurg Anesthesiol 8 (1996) 52-59
44. Cordoba J., Crespin J., Gottstein J., and Blei A.T. Mild hypothermia modifies ammonia-induced brain edema in rats after portacaval anastomosis. Gastroenterology 116 (1999) 686-693
45. Vaquero J., Bélanger M., James L., Herrero R., Desjardins P., Côté J., et al. Mild hypothermia attenuates liver injury and improves survival in mice with acetaminophen toxicity. Gastroenterology 132 (2007) 372-383
46. Kofman A.V., Morgan G., Kirschenbaum A., Osbeck J., Hussain M., Swenson S., et al. Dose- and time-dependent oval cell reaction in acetaminophen-induced murine liver injury. Hepatology 41 (2005) 1252-1261